CCR5 and progressive multifocal leukoencephalopathy: Preclinical studies aimed at delineating the behavior of CCR5+ JC-virus-specific T cells in blood and CSF are needed to support clinical trials assessing the impact of CCR5 antagonists in the context of inflammatory PML (57).